Fused ring inhibitors of hepatitis C

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9150554
APP PUB NO 20120040962A1
SERIAL NO

13260378

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are compounds of Formula I, pharmaceutical compositions comprising the same, and combination therapies comprising the same for treatment of hepatitis C.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PRESIDIO PHARMACEUTICALS INCCALIFORNIA USA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Li, Leping San Francisco, US 119 2017
Zhong, Min San Francisco, US 113 878

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 6, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00